ANDA 72707, held by Dava Pharms Inc. Prazosin Hydrochloride.
As of Nov 16, 2026, ANDA 72707 (Prazosin Hydrochloride), held by Dava Pharms Inc, was first approved by FDA on Mar 15, 1989, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 15, 1989 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prazosin HydrochlorideEQ 5MG BASE · capsule;oral | Prazosin Hydrochloride | Discontinued |
| Sep 6, 2001 | Supplement 10Manufacturing | Approved | None posted |
| Sep 6, 2001 | Supplement 9Manufacturing | Approved | None posted |
| Oct 6, 1998 | Supplement 8Manufacturing | Approved | None posted |
| May 11, 1995 | Supplement 5Manufacturing | Approved | None posted |
| Jul 28, 1994 | Supplement 6Manufacturing | Approved | None posted |
| Jun 28, 1994 | Supplement 7Manufacturing | Approved | None posted |
| Jan 22, 1992 | Supplement 2Manufacturing | Approved | None posted |
| Jan 22, 1992 | Supplement 1Manufacturing | Approved | None posted |
| Jan 17, 1991 | Supplement 4Labeling | Approved | None posted |
| Mar 15, 1989 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters